References
- 1
Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J. et al .
The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. I. Regional
changes in cerebral glucose metabolism differentiating patients and controls.
Neuropsychopharmacology.
1993;
9
277-291
- 2
Bubl E, Perlov E, Tebartz van Elst L.
Aripiprazole in patients with Tourette syndrome.
World J Biol Psychiatry.
2006;
7
123-125
- 3
Chae JH, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE. et al .
A review of functional neuroimaging studies of vagus nerve stimulation (VNS).
J Psychiatr Res.
2003;
37
443-455
- 4
Definitions and classification of tic disorders .
The Tourette Syndrome Classification Study Group.
Arch Neurol.
1993;
50
1013-1016
- 5
Eidelberg D, Moeller JR, Antonini A, Kazumata K, Dhawan V, Budman C. et al .
The metabolic anatomy of Tourette's syndrome.
Neurology.
1997;
48
927-934
- 6
Habermeyer B, Fuhr P, Hiss B, Alber C, Müller-Spahn F.
Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram.
A case report.
Pharmacopsychiatry.
2006;
39
193-194
- 7
Karadenizli D, Dilbaz N, Bayam G.
Gilles de la Tourette syndrome: response to electroconvulsive therapy.
J ECT.
2005;
21
246-248
- 8
Leckman JF, Riddle MA, Hardin MT, Ort SI, Schwartz KL, Stevenson J. et al .
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of
tic severity.
J Am Acad Child Adoles Psychiatry.
1989;
28
566-573
- 9
Moriarty J, Costa DC, Schmitz B, Trimble MR, ELL PJ, Robertson MM.
Brain perfusion abnormalities in Gilles de la Tourette's syndrome.
Br J Psychiatry.
1995;
167
249-254
- 10
Ozbay F, Wigg KG, Turanli ET, Asherson P, Yazgan Y, Sandor P. et al .
Analysis of the dopamine beta hydroxylase gene in Gilles de la Tourette syndrome.
Am J Med Genetics.
2006;
141
673-677
- 11
Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z. et al .
Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects,
and predictors of outcome.
Neuropsychopharmacology.
2001;
25
713-728
- 12 Shapiro AK, Shapiro ES, Young JG, Feinberg TE.
Gilles de la Tourette Syndrome 2nd edn. New York: Raven Press 1988
- 13
Eynde EF Van den, Naudts KH, Saedeleer S De, Heeringen C van, Audenaert K.
Olanzapine in Gilles de la Tourette syndrome: beyond tics.
Acta neurolog Belg.
2005;
105
206-211
- 14
Visser-Vanderwalle V, Ackermans L, Linden C van der, Temel Y, Tijssen MA, Schruers KR.
et al .
Deep brain stimulation in Gilles de la Tourette's syndrome.
Neurosurgery.
2006;
58
E590
1 Both authors contributed equally to this work.
Correspondence
Prof. W. SperlingMD
Department of Psychiatry and Psychotherapy
University Hospital of Erlangen
Schwabachanlage 6
91054 Erlangen
Germany
Phone: +49/9131/853 30 01
Fax: +49/9131/853 41 05
Email: wolfgang.sperling@uk-erlangen.de
